• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses

Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses

May 17, 2019 By Fink Densford

Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis.

Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the top ten highest paid CEOs on the list, which was calculated by using actual realized gains of stock options and awards listed in annual proxy disclosures filed with the SEC.

“The pay packages reveal the health care system’s real incentives: finding ways to boost revenue and stock value by raising prices, filling more hospital beds, and selling more drugs and devices,” Axios wrote in its report.

And even though the industry as a whole claims to be focused on value-based care, quality of care was either not a factor or a marginal one in all CEO bonuses, according to the report.

The median pay of a healthcare CEO in 2018 was $7.7 million, with 14 chief execs taking home more than $46 million per year, according to Axios.

To compare, the median household income in the U.S. last year as measured in June was $62,175, according to a report from Sentier Research.

Sunnyvale, Calif.-based Intuitive Surgical‘s (NSDQ:ISRG) Gary Guthart came in as the third most highly paid CEO on the list, netting a total of approximately $99.2 million in compensation during 2018, approximately 1,596 times greater than the median household in the U.S. last year.

Even in Sunnyvale, with a median household income of $118,314, as reported for 2017 by DataUsa, Guthart brought in pay approximately 839 times greater than the average worker.

Thermo Fisher Scientific‘s (NYSE:TMO) CEO Marc Casper received approximately $85.5 million sitting in the corner office last year, while Align Technology‘s (NSDQ:ALGN) Joe Hogan collected approximately $69.8 million, according to Axios.

Rounding out the top ten list are Masimo‘s (NSDQ:MASI) Joe Kiani who received approximately $61.3 million and Hill-Rom Holdings (NYSE:HRC) CEO Jon Greisch who took home a meager $59.1 million, 950 times greater than the median household income last year.

Johnson & Johnson (NYSE:JNJ), Edwards Lifesciences (NYSE:EW), PerkinElmer (NYSE:PKI), Abbott (NYSE:ABT) and Danaher‘s (NYSE:DHR) CEOs were also in the top 25 most highly paid chief execs in healthcare, with the lowest paid still making more than 400 times what the average U.S. worker took home last year.

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Abbott, aligntechnology, Danaher Corp., Edwards Lifesciences, Hillrom, Intuitive Surgical, Johnson and Johnson, Masimo, PerkinElmer Inc., Thermo Fisher Scientific

More recent news

  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy